   "); bodyStart = html.indexOf("
   ") + 10; bodyEnding = html.indexOf(""); if (titleStart > 0 && titleEnd
   > 0 && urlStart > 0 && urlEnd > 0 && nameStart > 0 && nameEnding > 0 &&
   bodyStart > 0 && bodyEnding > 0) { //title = html.substring(titleStart,
   titleEnd); title = html.substring(nameStart, nameEnding); bodyTxt =
   html.substring(bodyStart, bodyEnding).toString(); bodyTxt =
   bodyTxt.replace(regex1, ""); bodyTxt = bodyTxt.replace(regex2, ""); url
   = html.substring(urlStart, urlEnd);
   //document.getElementById("entitle").innerHTML = title + "
   Read More"; document.getElementById("entitle").innerHTML = "

   "+"

   " + bodyTxt + "

   " + "

   Read More

   " + "

   Click to close

   "; var container2012 = $( "#container2012" ); container2012.slideDown(
   1000 ); } setTimeout(checkEmergencyNotification, 60000); } function
   closewindow() { jQuery(function( $ ) { $.cookie("notified", true, {
   path: "/" }, { expires: 1 }); // Get a reference to the container var
   container2012 = $( "#container2012" ); container2012.slideUp( 1000 );
   }); } window.onload = function() { checkEmergencyNotification(); };

   Print Profile Print Profile

   christoph.schaniel@mssm.edu

   MS, University of Basel

   Ph.D., Basel Institute for Immunology/University of Basel

   Postdoctoral Fellow, Princeton University

   Lee DF, Su J, Kim HS, Chang B, Papatsenko D, Zhao R, Yuan Y, Gingold J,
   Xia W, Darr H, Mirzayans R, Hung MC, Schaniel C, Lemischka IR. Modeling
   Familial Cancer with Induced Pluripotent Stem Cells. Cell 2015; 161(2):
   240-254.

   Chaurasia P, Gajzer DC, Schaniel C, D'Souza SL, Hoffman R. Epigenetic
   Reprogramming Upregulates Pluripotency Genes in Cord Blood Stem Cells.
   Journal of Clinical Investestigation 2014; 124(6): 2378-2395.

   Qui J, Papatsenko D, Niu X, Schaniel C, Moore KA. Divisional history
   and hematopoietic stem cell function during homeostasis. Stem Cell
   Reports 2014; 2(4): 473-490.

   Pereira CF, Chang B, Qiu J, Niu X, Papatsenko D, Hendry CE, Clark NR,
   Nomura-Kitabayashi A, Kovacic JC, Ma'ayan A, Schaniel C, Lemischka IR,
   Moore K. Induction of a Hemogenic Program in Mouse Fibroblasts. Cell
   Stem Cell 2013; 13(2): 205-218.

   Gaspar-Maia A, Qadeer ZA, Hasson D, Ratnakumar K, Adrian Leu N, Leroy
   G, Liu S, Costanzi C, Valle-Garcia D, Schaniel C, Lemischka I, Garcia
   B, Pehrson JR, Bernstein E. MacroH2A histone variants act as a barrier
   upon reprogramming towards pluripotency. Nature Communications 2013; 4:
   1565.

   Fidalgo M, Faiola F, Pereira CF, Ding J, Saunders A, Gingold J,
   Schaniel C, Lemischka IR, Silva JC, Wang J. Zfp281 Mediates Nanog
   Autorepression through Recruits of the NuRD Repressor Complex and
   Inhibits Somatic Cell Reprogramming. Proc. Nat. Acad. Sci. 2012; 109:
   16202-16207.

   Young W, D'Souza SL, Lemischka IR, Schaniel C. Patient-specific induced
   pluripotent stem cells as a platform for disease modeling, drug
   discovery and precision personalized medicine. The Journal of Stem Cell
   Research & Therapy 2012; S10-010.

   Lee DF, Su J, Ang YS, Carvajal-Vergara X, Mulero-Navarro S, Pereira CF,
   Gingold J, Wang HL, Zhao R, Sevilla A, Darr H, Williamson AJ, Chang B,
   Niu X, Aguilo F, Flores ER, Sher YP, Hung MC, Whetton AD, Gelb BD,
   Moore KA, Snoeck HW, Ma'ayan A, Schaniel C, Lemischka IR. Regulation of
   embryonic and induced pluripotency by Aurora kinase-p53 signaling. Cell
   Stem Cell 2012; 11(2): 179-194.

   Chang B, Lemischka IR, Schaniel C. MicroRNAs in development, stem cell
   differentiation and regenerative medicine. In: Regulatory RNAs .
   Springer; pp409-442.

   Schaniel C, Sirabella D, Qiu J, Niu X, Lemischka IR, Moore KA.
   Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts
   hematopoietic stem cells. Blood 2011; 118(9): 2420-2429.

   Ang YS, Tsai SY, Lee DF, Monk J, Su J, Ratnakumar K, Ding J, Ge Y, Darr
   H, Chang B, Wang J, Rendl M, Bernstein E, Schaniel C, Lemischka IR.
   Wdr5 mediates self-renewal and reprogramming via the embryonic stem
   cell core transcriptional network. Cell 2011; 145(2): 183-197.

   Xu H, Schaniel C, Lemischka IR, Ma'ayan A. Toward a complete in silico,
   multi-layered embryonic stem cell regulatory network [review]. Wiley
   Interdisciplinary Reviews. Systems Biology and Medicine 2010; 2(6):
   708-733.

   Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang YS, Schaniel C, Lee D,
   Yang L, Kaplan AD, Adler ED, Rozov R, Ge Y, Cohen N, Edelmann LJ, Chang
   B, Waghray A, Su J, Pardo S, Lichtenbelt KD, Tartaglia M, Gelb BD,
   Lemischka IR. Patient-specific induced pluripotent stem-cell-derived
   models of LEOPARD syndrome. Nature 2010; 465(7299): 808-812.

   Schaniel C, Moore KA. Genetic models to study quiescent stem cells and
   their niches. Ann N Y Acad Sci 2009; 1176: 26-35.

   Schaniel C, Ang YS, Ratnakumar K, Cormier C, James T, Bernstein E,
   Lemischka IR, Paddison PJ. Smarcc1/Baf155 couples self-renewal gene
   repression with changes in chromatin structure in mouse embryonic stem
   cells. Stem Cells 2009; 27(12): 2979-2991.

   Physicians and scientists on the faculty of the Icahn School of
   Medicine at Mount Sinai often interact with pharmaceutical, device and
   biotechnology companies to improve patient care, develop new therapies
   and achieve scientific breakthroughs. In order to promote an ethical
   and transparent environment for conducting research, providing clinical
   care and teaching, Mount Sinai requires that salaried faculty inform
   the School of their relationships with such companies.

   Dr. Schaniel did not report having any of the following types of
   financial relationships with industry during 2014 and/or 2015:
   consulting, scientific advisory board, industry-sponsored lectures,
   service on Board of Directors, participation on industry-sponsored
   committees, equity ownership valued at greater than 5% of a publicly
   traded company or any value in a privately held company. Please note
   that this information may differ from information posted on corporate
   sites due to timing or classification differences.

   Mount Sinai's faculty policies relating to faculty collaboration with
   industry are posted on our website. Patients may wish to ask their
   physician about the activities they perform for companies.

   Edit profile in Sinai Central

   Icahn Medical Institute Floor 13 Room 70F
   1425 Madison Avenue
   New York, NY 10029
file:///var/folders/07/q1dxpd8s56s0tfqh7n6xv3rm0000gn/T/"%20+%20url%20+%20"
file:///var/folders/07/q1dxpd8s56s0tfqh7n6xv3rm0000gn/T/"%20+%20url%20+%20"
file:///var/folders/07/q1dxpd8s56s0tfqh7n6xv3rm0000gn/T/L49811-6566TMP.html
javascript:window.print()
mailto:christoph.schaniel@mssm.edu
http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook
http://sinaicentral.mssm.edu/
